An oral pyruvate kinase (PK) activator, mitapivat becomes the only approved option for treating anemia in both ...

Approval was based on the phase 3 ENERGIZE and ENERGIZE-T studies evaluating the safety and efficacy of mitapivat in adults with alpha- or beta-thalassemia.

The biopharmaceutical company said Tuesday that Aqvesme is now the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia.

Caden Major was born with sickle cell disease – an inherited blood disorder affecting red blood cells. Now at 19 years old, ...

Medically reviewed by Andrea L. Braden, MD Key Takeaways Anemia can make you feel tired because your body isn't getting ...

FDA approves Agios' Aqvesme for anemia in alpha and beta thalassemia, backed by Phase 3 data and a REMS safety program.

Major is one of the first pediatric patients in Florida to receive gene therapy for sickle cell disease since the FDA ...

Severe Aplastic Anemia is a rare, life-threatening hematologic disorder in which the bone marrow fails to produce sufficient blood cells. Stem cell transplantation offers a potential cure; however, ...

While anemia is not a typical symptom of IBS, people with IBS may develop anemia if they cannot absorb enough iron from their food. Irritable bowel syndrome (IBS) is a common gastrointestinal disorder ...

SAGINAW, Mich. (WNEM) - At just 10 years old, Elijah Dottery has already faced more challenges than most people will in a ...

Iron deficiency without anemia is a common feature of moderate-to-severe atopic dermatitis (AD), according to a study ...

Agios Pharmaceuticals has announced a major regulatory milestone with the U.S. Food and Drug Administration approving ...